StartsidaATBPF • OTCMKTS
add
Antibe Therapeutics Ord Shs
Föregående stängning
0,22 $
Årsintervall
0,11 $ - 0,89 $
Genomsnittlig volym
27,54 tn
P/E-tal
-
Direktavkastning
-
Ekonominyheter
Ekonomi
Resultaträkning
Intäkter
Nettoinkomst
| (CAD) | dec. 2023info | Förändring Y/Y |
|---|---|---|
Intäkter | — | — |
Rörliga kostnader | 4,60 mn | −1,42 % |
Nettoinkomst | −4,21 mn | 2,39 % |
Nettovinstmarginal | — | — |
Vinst per aktie | −0,08 | 0,50 % |
EBITDA | — | — |
Giltig skattesats | — | — |
Balansräkning
Totala tillgångar
Totala ansvarsskyldigheter
| (CAD) | dec. 2023info | Förändring Y/Y |
|---|---|---|
Kontanta och kortsiktiga investeringar | 24,91 mn | −41,20 % |
Totala tillgångar | 56,36 mn | −23,56 % |
Totala ansvarsskyldigheter | 30,42 mn | −0,13 % |
Totala tillgångar | 25,94 mn | — |
Utestående aktier | 52,67 mn | — |
P/B | 0,44 | — |
Avkastning på tillgångar | −19,71 % | — |
Avkastning på kapital | −41,30 % | — |
Kassaflöde
Förändring i nettokassa
| (CAD) | dec. 2023info | Förändring Y/Y |
|---|---|---|
Nettoinkomst | −4,21 mn | 2,39 % |
Kontanter från verksamhet | −3,84 mn | −6,66 % |
Kontanter från investering | 11,04 mn | 1 975,38 % |
Kontanter från finansiering | — | — |
Förändring i nettokassa | 7,20 mn | 334,09 % |
Fritt kassaflöde | −2,47 mn | −2 419,13 % |
Om
Antibe Therapeutics was a Toronto-based pharmaceutical company that develops pain and inflammation-reducing drugs based on gaseous mediator technology. Antibe was founded by John L. Wallace, also a co-founder of NicOx, the first company to develop drugs utilizing gaseous mediators. Founded in 2009, the company listed on the TSX Venture Exchange in 2013 and was moved to the Toronto Stock Exchange in November 2020. In 2015, Antibe acquired Citagenix, a distributor involved in regenerative medicine.
On June 1, 2020, the company announced positive results in the final Phase 2 trial of its first drug Otenaproxesul.
On March 29, 2021, the drug's Investigational New Drug application was cleared by the US Food and Drug Administration, allowing for human trials.
In May 2024 the company went bankrupt and its stock was delisted from the Toronto Stock Exchange. Wikipedia
Grundades
2009
Hemsida
Anställda
11
